Patients with colorectal cancer will develop recurrence of the disease with greater than 90% having it in the first 5 years following surgery. If detected early, may be amenable to potentially curative surgical resection. This provides the rationale for a follow-up strategy in patients with resected colorectal cancer. We report a case of a 68-year-old female who had a loco regional recurrence after 13 years of primary surgery involving the middle part of sacrum, raising the question regarding the long term surveillance.
INTRODUCTION
Intensive follow up, after colorectal surgery, has been suggested by different guide lines as most of the recurrence occurs early in the first five years post surgery. Following rectal cancer surgical resection loco regional recurrence is the most common type of failure and can be debilitating causing significant morbidity and decreased life expectancy.
REPORT OF A CASE
A 68-year-old female presented with anal pain and difficulty in evacuation for the previous one year. She was operated for recto-sigmoid tumour and had anterior resection PT2N0M0, thirteen years ago. On examination abdomen was soft, perrectal examination did not show any fissure or mass in the rectum. Her CEA was elevated at 19.6. She had surveillance colonoscopy a year ago which was repeated again. It did not show any intraluminal recurrence. She had CT TAP done (see Figure 1 ) which showed 3 cm enhancing soft tissue mass in the anterior mid sacral area which was biopsied showing appearance consistent with the late recurrence of the previously diagnosed colorectal adenocarcinoma (see Figure 2 ). The tumour cells exhibit positive staining with CK 19, CK20, CDX2 and CEA while negative for CK7. She had PET CT (see Figure 3 ) whole body done which showed high FDG uptake in the 3 cm soft tissue mass in the presacral area corresponding with the tumour identified on the recent CT. The patient was discussed in the MDM meeting and was planned for chemo radiation and possible surgery for which she was planned to be referred to a tertiary care centre. 
DISCUSSION
Recurrence of colorectal cancer (CRC) occurs in about 30%-40% of patients who have undergone primary curative surgical resection with majority occurring in the first two years after surgery. [1] Various guidelines such as ASCO, NCCN, CCO advises intensive surveillance during the first 5 years after surgery with curative intent for early detection of metastatic disease or local recurrence so that surgical resection is an option for cure and improve survival. Renehan et al. [2] and Figueredo et al. [3] reported it detects recurrence and improves survival and reported 20%-33% reduction in risk of death. Tsikitis et al. in (COST trial) found that salvage rates for early and late-stage colon cancer with recurrence were the same (35.9% vs. 37%). [4] Locally recurrent rectal cancer causes significant morbidity and mortality though total mesorectal excision and improved chemo-radio therapeutic regimens has resulted in decreased locoregional rectal cancer recurrence rates from 25%-40% to 4%-8%. [5] J. Faivre et al. reported 5-year cumulative rate of 12.8% for local recurrence and 25.6% for distant metastases. [6] Ann-Marie Bouvier et al, stated overall cumulative recurrence rate of 2.9% for local recurrence and 4.3% for distant metastasis between 5-10 years. [7] J.C. Kim et al. reported 4.3% recurrence rate > 5 years after surgery. [8] All these studies prove that there is a group of patients which can have delayed loco-regional recurrence depending on the stage of the disease and need to be followed.
Delayed recurrence after 13 years is unusual, as in my patient, and raises the question about the post-operative surveillance protocols and long term surveillance. No guidelines or recommendation is available at present concerning the detection of late recurrences and leaves it to the discretion of the physician. Merkel et al, recommended at least 7-8 years of follow-up after long-term neoadjuvant radiotherapy or chemo radiotherapy for rectal cancer. [9] Recent studies have reported higher rates of skeletal metastasis Sundermeyer et al, reported 10.4% of patients developed bony metastases. [10] Katoh et al, reported bony metastasis of 23.7%. [11] Time interval and survival following diagnosis is variable. Talbot et al. [12] described a median time of 21 months and Chalkidou et al. reported a solitary tibial metastasis from rectal cancer 12 months after surgery. [13] In our case the metastasis was diagnosed 13 years after resection of the tumour.
In sacral recurrence, the outlook is serious with severe pain and a life expectancy of only 6-7 months. [14] The common presentation is pain, neurological deficit including motor or sphincter dysfunction. [15] Refractory pelvic pain, tenesmus and malodorous discharge are also common. [16] Risk factors associated with loco regional recurrence are degree of lympho-vascular invasion, differentiation and tumour size, [17] positive circumferential or distal resection margin at initial resection. Patients operated in high volume centres have lower recurrence rates. [18] Abdominoperineal resection has been associated with higher recurrence rates than sphincter-preserving surgery. [19] Trans-anal endoscopic microsurgery may also increase risk of recurrence rate which varies according to stage.
Most metastatic disease to the sacrum is treated with radiation, chemotherapy or both. Failure of treatment calls for surgical intervention which should be performed in a tertiary care centre. Sacrectomies are divided into high and low or total when it involves the entire sacrum, high sacrectomy involves S3 cut whereas low involves S4 and lower. Surgery is usually not indicated for S1/S2 lesions because of the high risk of neurological complications. The major issue in doing these procedures are haemorrhage and neurological deficit. Sciatic nerve dysfunction is seen more in case of high sacrectomy along with urogenital dysfunction, where as patients having undergone low sacrectomy have a better quality of life from the sexual, mobility and pain management point of view. However, in a recent study by Milne et al. [20] compared both the high and low sacral resection and reported no major difference in complications. Postoperative morbidity in this procedure is high, ranging from 15%-70% which increases with the complexity of resection performed. [21, 22] Moriya et al. in their study reported sacral wound dehiscence in 51%, followed by pelvic sepsis in 39%, walking impairment and spinal fluid leak did not occur since the preservation of the S2 sacral nerves bilaterally. [23] 
CONCLUSION
Any symptoms post bowel cancer surgery should be looked into with high degree of suspicion and investigated. Sacral recurrence requires multidisciplinary approach in a tertiary care centre. Delayed recurrence raises the question of long term follow up and the use of another modality such as endoanal ultrasound or MRI Pelvis as a tool for follow up which needs to be looked into.
